PeptidePedia The community reference

Shanghai Wibson Biotechnology: difference between revisions

Diff·revision 11 → 12·02:00, 18 Feb 2025

Difference between revision 11 and revision 12 of Shanghai Wibson Biotechnology. 3 lines changed; the page grew by 696 bytes.

Revision 11 — 21:03, 14 Feb 2025
IncretinIvo (talk)
fix unit
2,479 bytes ±0		Revision 12 — 02:00, 18 Feb 2025
SemaglutideSasha (talk)
add citation for the incidence figure
3,175 bytes +696
10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}
1111
+12This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}}
+13
12== Corporate identity and history ==14== Corporate identity and history ==
13Incorporated in 2019, the organisation is among the more recently established covered on this wiki, and its operating record is correspondingly shorter.{{r|registry}} A short history is not a defect and is not treated as one here; it does mean that observations about consistency rest on fewer years of reports than for the older entities.15Incorporated in 2019, the organisation is among the more recently established covered on this wiki, and its operating record is correspondingly shorter.{{r|registry}} A short history is not a defect and is not treated as one here; it does mean that observations about consistency rest on fewer years of reports than for the older entities.
⋮⋮
19<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>21<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>
20<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>22<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
+23<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>
21<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>24<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
2225